AAV2/8 Vectors Purified from Culture Medium with a Simple and Rapid Protocol Transduce Murine Liver, Muscle, and Retina Efficiently

被引:50
作者
Doria, Monica [1 ]
Ferrara, Antonella [1 ]
Auricchio, Alberto [1 ,2 ]
机构
[1] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Translat Med, I-80131 Naples, Italy
关键词
RECOMBINANT ADENOASSOCIATED VIRUS; ION-EXCHANGE CHROMATOGRAPHY; VIRAL VECTORS; GENE-TRANSFER; SCALABLE PURIFICATION; TYPE-2; SEROTYPE; VERSATILE; THERAPY; COLUMN;
D O I
10.1089/hgtb.2013.155
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
During the production of some adeno-associated virus (AAV) serotypes, a large amount of vectors is found in the medium of producing cells. For their purification, previous protocols used tangential flow filtration (TFF) of the medium followed by iodixanol gradient centrifugation. Taking advantage of the higher purity of the medium than the cell-derived material as the source of AAV, we tested a simple method that combines production of large culture medium volumes containing AAV from cell stacks with medium clarification + TFF without further time-consuming and nonscalable centrifugation. To test this, we selected AAV2/8, which is emerging as a favored serotype for transduction of liver, muscle, and retina and abundantly found in the extracellular medium. We show that yields and in vitro infectivity of AAV2/8 vectors produced from the culture medium using this method are higher than those of vectors purified from the same cell lysate using a conventional CsCl2 gradient ultracentrifugation-based method, although purity appears inferior. In addition, we found that the transduction efficiency of AAV2/8 purified from medium was similar to that of AAV2/8 purified from the same cell lysate in the murine liver, muscle, and retina. Considering that the purification protocol from the medium we describe requires 3 hr as opposed to the 63 hr of a conventional two-round CsCl2-gradient ultracentrifugation + desalting, we conclude that TFF of the medium containing AAV2/ 8 represents a quick and scalable method to purify research-grade vectors for use in animal models.
引用
收藏
页码:392 / 398
页数:7
相关论文
共 26 条
[1]
Anderson R, 2000, NAT HIST, V109, P23
[2]
Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column [J].
Auricchio, A ;
Hildinger, M ;
O'Connor, E ;
Gao, GP ;
Wilson, JM .
HUMAN GENE THERAPY, 2001, 12 (01) :71-76
[3]
Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences [J].
Aurnhammer, Christine ;
Haase, Maren ;
Muether, Nadine ;
Hausl, Martin ;
Rauschhuber, Christina ;
Huber, Ingrid ;
Nitschko, Hans ;
Busch, Ulrich ;
Sing, Andreas ;
Ehrhardt, Anja ;
Baiker, Armin .
HUMAN GENE THERAPY METHODS, 2012, 23 (01) :18-28
[4]
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency [J].
Ayuso, E. ;
Mingozzi, F. ;
Montane, J. ;
Leon, X. ;
Anguela, X. M. ;
Haurigot, V. ;
Edmonson, S. A. ;
Africa, L. ;
Zhou, S. ;
High, K. A. ;
Bosch, F. ;
Wright, J. F. .
GENE THERAPY, 2010, 17 (04) :503-510
[5]
A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and-5 [J].
Brument, N ;
Morenweiser, R ;
Blouin, V ;
Toublanc, E ;
Raimbaud, I ;
Chérel, Y ;
Folliot, S ;
Gaden, F ;
Boulanger, P ;
Kroner-Lux, G ;
Moullier, P ;
Rolling, F ;
Salvetti, A .
MOLECULAR THERAPY, 2002, 6 (05) :678-686
[6]
Brunetti-Pierri N, 2010, MILESTONES DRUG THER, P193, DOI 10.1007/978-3-0346-0165-8_13
[7]
Gene Therapy of Inherited Retinopathies: A Long and Successful Road from Viral Vectors to Patients [J].
Colella, Pasqualina ;
Auricchio, Alberto .
HUMAN GENE THERAPY, 2012, 23 (08) :796-807
[8]
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy [J].
Gao, GP ;
Alvira, MR ;
Wang, LL ;
Calcedo, R ;
Johnston, J ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11854-11859
[9]
Novel tools for production and purification of recombinant adenoassociated virus vectors [J].
Grimm, D ;
Kern, A ;
Rittner, K ;
Kleinschmidt, JA .
HUMAN GENE THERAPY, 1998, 9 (18) :2745-2760
[10]
Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system [J].
Hermens, WTJMC ;
Ter Brake, O ;
Dijkhuizen, PA ;
Sonnemans, MAF ;
Grimm, D ;
Kleinschmidt, JA ;
Verhaagen, J .
HUMAN GENE THERAPY, 1999, 10 (11) :1885-1891